---
document_datetime: 2023-09-21 19:22:32
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/revatio-epar-all-authorised-presentations_en.pdf
document_name: revatio-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.4898266
conversion_datetime: 2025-12-14 14:39:22.308334
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form        | Route of Administration   | Immediate Packaging   | Content (concentration)   | Pack size                  |
|------------------|-------------------|------------|----------------------------|---------------------------|-----------------------|---------------------------|----------------------------|
| EU/1/05/318/001  | Revatio           | 20 mg      | Film-coated tablet         | Oral use                  | blister (PVC/alu)     |                           | 90 tablets                 |
| EU/1/05/318/002  | Revatio           | 0.8 mg/ml  | Solution for injection     | Intravenous use           | vial (glass)          | 20 ml                     | 1 vial                     |
| EU/1/05/318/003  | Revatio           | 10 mg/ml   | Powder for oral suspension | Oral use                  | bottle (glass)        | 32.27 g                   | 1 bottle                   |
| EU/1/05/318/004  | Revatio           | 20 mg      | Film-coated tablet         | Oral use                  | blister (PVC/alu)     |                           | 300 tablets                |
| EU/1/05/318/005  | Revatio           | 20 mg      | Film-coated tablet         | Oral use                  | blister (PVC/alu)     |                           | 90 x 1 tablets (unit dose) |